PRICE T ROWE ASSOCIATES INC /MD/ - IMMUNITYBIO INC ownership

IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 124 filers reported holding IMMUNITYBIO INC in Q3 2021. The put-call ratio across all filers is 3.72 and the average weighting 0.0%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of IMMUNITYBIO INC
ValueSharesWeighting
Q3 2023$187
-53.0%
110,512
-22.5%
0.00%
Q2 2023$398
+30.9%
142,540
-14.5%
0.00%
Q1 2023$304
-60.0%
166,758
+11.2%
0.00%
Q4 2022$760
-99.9%
149,958
-5.0%
0.00%
Q3 2022$785,000
+43.8%
157,866
+7.6%
0.00%
Q2 2022$546,000
-41.0%
146,717
-11.1%
0.00%
Q1 2022$926,000
-20.4%
165,121
-13.7%
0.00%
Q4 2021$1,164,000
-34.4%
191,402
+5.1%
0.00%
Q3 2021$1,774,000
-42.2%
182,102
-15.3%
0.00%
Q2 2021$3,070,000
-36.3%
215,008
+5.9%
0.00%
Q1 2021$4,818,000202,9380.00%
Other shareholders
IMMUNITYBIO INC shareholders Q3 2021
NameSharesValueWeighting ↓
ALLEN HOLDING INC /NY 687,571$4,180,0000.56%
HARBOURVEST PARTNERS LLC 335,709$2,041,0000.26%
MERIDIAN INVESTMENT COUNSEL INC. 96,433$586,0000.20%
SHEETS SMITH WEALTH MANAGEMENT 152,276$926,0000.12%
GSA CAPITAL PARTNERS LLP 129,260$786,0000.10%
Clearwater Capital Advisors, LLC 140,551$855,0000.09%
Virtus ETF Advisers LLC 28,969$176,0000.07%
XTX Topco Ltd 19,159$116,0000.07%
LIBERTY ONE INVESTMENT MANAGEMENT, LLC 49,464$301,0000.04%
Vident Investment Advisory, LLC 168,476$1,024,0000.03%
View complete list of IMMUNITYBIO INC shareholders